Alport Syndrome Panel
New York
Approved
Genes
Conditions
- Alport Syndrome
Clinical Utility
- Molecular confirmation of a clinical diagnosis
- Development of appropriate evaluation and management plan
- Differentiation between X-linked and autosomal recessive or dominant forms of the disease
- Evaluation of family members as possible donors for kidney transplantation
- Testing of at-risk relatives for specific known variant(s) previously identified in an affected family member
- Genetic counseling, especially recurrence risk
Lab Method
- Next-Gen Sequencing
- Deletion/Duplication Analysis
Test Code
TG21
CPT Codes*
81407x1, 81408x2, 81479x1
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing